Analysts
Scores, price targets and rating changes published by the firms we track. Informational, not advice.
Price target forecast
The average analyst target through the past year, and where analysts see the price a year from now.
Nov 6, 20260 analyst targets · 90 days
- Share price
- $84.43
- Average 1Y price target
- $136.00+61.08%
- Agreement
- Good
Analysts agreement range is spread less than 15% from the average
Share priceAverage analyst target (90-day window), shaded 10th–90th percentile12-month range from the lowest to the highest current target, dashed to the average
Rating scores
Each factor is scored 1 (weak) to 5 (strong).
- Overall3
- DCF4
- Return on equity5
- Return on assets4
- Debt / equity2
- P/E2
- P/B2
Average price target
Mean of the targets analysts published in each window.
| Window | Targets | Average |
|---|---|---|
| Last month | 0 | — |
| Last quarter | 1 | $116.00 |
| Last year | 4 | $117.00 |
| All time | 11 | $124.27 |
Recent rating changes
The latest 40 changes by research firm, newest first.
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 26, 2026 | Citigroup | maintain | Buy | Buy |
| Oct 22, 2026 | UBS | maintain | Buy | Buy |
| Oct 22, 2026 | RBC Capital | maintain | Outperform | Outperform |
| Oct 22, 2026 | Barclays | maintain | Overweight | Overweight |
| Oct 19, 2026 | Piper Sandler | maintain | Overweight | Overweight |
| Oct 19, 2026 | Citigroup | maintain | Buy | Buy |
| Oct 15, 2026 | Barclays | maintain | Overweight | Overweight |
| Oct 14, 2026 | Goldman Sachs | maintain | Neutral | Neutral |
| Sep 23, 2026 | UBS | maintain | Buy | Buy |
| Jul 29, 2026 | UBS | upgrade | Neutral | Buy |
| Jul 24, 2026 | Barclays | maintain | Overweight | Overweight |
| Jul 16, 2026 | Barclays | maintain | Overweight | Overweight |
| Jul 10, 2026 | Raymond James | maintain | Outperform | Outperform |
| Jun 26, 2026 | Citigroup | maintain | Buy | Buy |
| Jun 3, 2026 | Citigroup | maintain | Buy | Buy |
| May 8, 2026 | Barclays | maintain | Overweight | Overweight |
| May 4, 2026 | Citigroup | maintain | Buy | Buy |
| Apr 23, 2026 | UBS | maintain | Neutral | Neutral |
| Apr 23, 2026 | Piper Sandler | maintain | Overweight | Overweight |
| Apr 15, 2026 | Piper Sandler | maintain | Overweight | Overweight |
| Apr 9, 2026 | Barclays | maintain | Overweight | Overweight |
| Mar 31, 2026 | UBS | maintain | Neutral | Neutral |
| Mar 4, 2026 | Goldman Sachs | maintain | Neutral | Neutral |
| Feb 13, 2026 | Citigroup | maintain | Buy | Buy |
| Feb 5, 2026 | UBS | maintain | Neutral | Neutral |
| Jan 23, 2026 | Barclays | maintain | Overweight | Overweight |
| Dec 18, 2025 | Piper Sandler | maintain | Overweight | Overweight |
| Dec 17, 2025 | Barclays | maintain | Overweight | Overweight |
| Dec 11, 2025 | Citigroup | maintain | Buy | Buy |
| Nov 5, 2025 | Goldman Sachs | maintain | Neutral | Neutral |
| Oct 24, 2025 | Barclays | maintain | Overweight | Overweight |
| Oct 23, 2025 | Piper Sandler | maintain | Overweight | Overweight |
| Oct 16, 2025 | Piper Sandler | maintain | Overweight | Overweight |
| Jul 28, 2025 | Piper Sandler | upgrade | Neutral | Overweight |
| Jul 24, 2025 | Raymond James | maintain | Outperform | Outperform |
| Jul 24, 2025 | Barclays | maintain | Overweight | Overweight |
| May 13, 2025 | Citigroup | maintain | Buy | Buy |
| Apr 25, 2025 | Barclays | maintain | Overweight | Overweight |
| Apr 24, 2025 | Raymond James | downgrade | Strong Buy | Outperform |
| Apr 24, 2025 | Piper Sandler | maintain | Neutral | Neutral |